ABBV · NYSE · Drug Manufacturers - General

AbbVie (ABBV)

Develops immunology, neuroscience, oncology, and aesthetics products led by Skyrizi and Rinvoq.

$265.29
After hours+0.02 (+0.01%)
At close$265.27(+0.30%)